Studies examining the synergy between Dihydrotanshinone and Temozolomide against MGMT+ glioblastoma cells in vitro: Predicting interactions with the blood-brain barrier-Reference-Cited by-同舟云学术

Studies examining the synergy between Dihydrotanshinone and Temozolomide against MGMT+ glioblastoma cells in vitro: Predicting interactions with the blood-brain barrier

Published:2019-01 Issue: Volume:109 Page:386-390
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Kumar Varun,Radin Daniel,Leonardi Donna

Funder

Bergen County Academies

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference15 articles.

1. DNA repair mechanisms and their clinical impact in glioblastoma;Erasimus;Mutat. Res. Mutat. Res.,2016

2. Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells;Munoz;Cancer Lett.,2015

3. Advances in glioblastoma multiforme treatment: new models for nanoparticle therapy;Ozdemir-Kaynak;Front. Physiol.,2018

4. TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma;Lv;Nat. Commun.,2017

5. Probing the oncolytic and chemosensitizing effects of dihydrotanshinone in an in vitro glioblastoma model;Kumar;Anticancer Res.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil;Biomedicines;2023-04-03

2. Role of NF-kB in Brain Tumor Development;Role of Signaling Pathways in Brain Tumorigenesis;2023

3. Terpenes: A hope for glioblastoma patients;New Insights Into Glioblastoma;2023

4. Salvia miltiorrhiza in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes;Frontiers in Pharmacology;2022-09-12

5. Lucanthone Targets Lysosomes to Perturb Glioma Proliferation, Chemoresistance and Stemness, and Slows Tumor Growth In Vivo;Frontiers in Oncology;2022-04-14